A KATP channel opener inhibited myocardial reperfusion action potential shortening and arrhythmias

European Journal of Pharmacology

Volumn 419, Issue 1, 2001, Pages 73-83

  Workman, Antony J ^a,b   MacKenzie, Ian ^a   Northover, Basil J ^a  

^a DE MONTFORT UNIVERSITY   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

Action potential; ATP sensitive; Heart; Isolated; K+ channel; Reperfusion; Ventricular arrhythmia

Indexed keywords

2 (6 CYANO 2,2 DIMETHYL 2H 1 BENZOPYRAN 4 YL)PYRIDINE 1 OXIDE; GLIBENCLAMIDE; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM CHANNEL STIMULATING AGENT;

ACTION POTENTIAL; ANIMAL MODEL; ANIMAL TISSUE; ARRHYTHMOGENESIS; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE DURATION; DRUG EFFECT; DRUG SENSITIVITY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEART REPOLARIZATION; HEART VENTRICLE; HEART VENTRICLE TACHYCARDIA; INCIDENCE; ISOLATED HEART; NONHUMAN; PRIORITY JOURNAL; RAT;

ACTION POTENTIALS; ADENOSINE TRIPHOSPHATE; ANIMALS; ANTIHYPERTENSIVE AGENTS; ARRHYTHMIA; BENZOPYRANS; DOSE-RESPONSE RELATIONSHIP, DRUG; GLYBURIDE; HEART; HYPOGLYCEMIC AGENTS; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION; MYOCARDIAL REPERFUSION INJURY; POTASSIUM CHANNELS; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0035805341     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(01)00972-4     Document Type: Article

References (56)

1. +-ATPase activity in regionally ischemic rat hearts. Am. J. Physiol. 270:1996;H957-H964.
2. ATP-channel openers protect against increased systolic calcium during ischaemia and reperfusion. J. Mol. Cell. Cardiol. 27:1995;1809-1817.
3. + channel modulators on an ischemia-reperfusion rabbit isolated heart model with programmed electrical stimulation. Eur. J. Pharmacol. 256:1994;115-124.
4. + channel blocking agent glibenclamide on ischaemic and reperfusion arrhythmias. Eur. J. Pharmacol. 326:1997;147-156.
5. Billman G.E., Avendano C.E., Halliwill J.R., Burroughs J.M. The effect of the ATP-dependent potassium channel antagonist glyburide on coronary blood flow and susceptibility to ventricular fibrillation in unanaesthetised dogs. J. Cardiovasc. Pharmacol. 21:1993;197-204.
6. Bott A., Eltze M., Illes P. External ATP antagonizes the effect of potassium channel openers in guinea-pig ventricular papillary muscle. Eur. J. Pharmacol. 213:1992;141-144.
7. Bril A., Laville M.-P., Gout B. Effects of glibenclamide on ventricular arrhythmias and cardiac function in ischaemia and reperfusion in isolated rat heart. Cardiovasc. Res. 26:1992;1069-1076.
8. Chi L., Uprichard A.C.G., Lucchesi B.R. Profibrillatory actions of pinacidil in a conscious canine model of sudden coronary death. J. Cardiovasc. Pharmacol. 15:1990;452-464.
9. Coronel R., Wilms-Schopman F.J.G., Opthof T., Cinca J., Fiolet J.W.T., Janse M.J. Reperfusion arrhythmias in isolated perfused pig hearts: inhomogeneities in extracellular potassium, ST and TQ potentials, and transmembrane action potentials. Circ. Res. 71:1992;1131-1142.
10. Culling W., Penny W.J., Sheridan D.J. Effects of sotalol on arrhythmias and electrophysiology during myocardial ischaemia and reperfusion. Cardiovasc. Res. 18:1984;397-404.
11. D'Alonzo A.J., Hess T.A., Darbenzio R.B., Sewter J.C. Effect of intracoronary cromakalim, pinacidil, or diltiazem on cesium chloride-induced arrhythmias in anesthetised dogs under conditions of controlled coronary blood flow. J. Cardiovasc. Pharmacol. 21:1993;677-683.
12. Di Diego J.M., Antzelevitch C. Pinacidil-induced electrical heterogeneity and extrasystolic activity in canine ventricular tissue. Circulation. 88:1993;1177-1189.
13. 31P NMR studies. J. Mol. Cell. Cardiol. 29:1997;1665-1673.
14. Edwards G., Henshaw M., Miller M., Weston A.H. Comparison of the effects of several potassium-channel openers on rat bladder and rat portal vein in vitro. Br. J. Pharmacol. 102:1991;679-686.
15. ATP channel modulation in working rat hearts with coronary occlusion: effects of cromakalim, cicletanine, and glibenclamide. Cardiovasc. Res. 30:1995;781-787.
16. Ferrier G.R., Guyette C.M., Li G.R. Cellular mechanisms of reperfusion arrhythmias: studies in isolated ventricular tissue preparations. Zipes D., Jalife J. Cardiac electrophysiology: from cell to bedside. 1990;433 WB Saunders, Philadelphia.
17. Finta E., Harms L., Sevcik J., Fischer H.-D., Illes P. Effects of potassium channel openers and their antagonists on rat locus coeruleus neurones. Br. J. Pharmacol. 109:1993;308-315.
18. ATP in the heart - what happens, and what does not happen. Basic Res. Cardiol. 95:2000;275-279.
19. Goldberg S., Greenspon A.J., Urban P.L., Muza B., Berger B., Walinsky P., Maroko P.R. Reperfusion arrhythmia: a marker of restoration of antegrade flow during intracoronary thrombolysis for acute myocardial infarction. Am. Heart J. 105:1983;26-32.
20. + currents recorded from cultured ovine trachea submucosal gland cells. Respir. Physiol. 96:1994;297-309.
21. Grover G.J., Garlid K.D. ATP-sensitive potassium channels: a review of their cardioprotective pharmacology. J. Mol. Cell. Cardiol. 32:2000;677-695.
22. Grover G.J., Dzwonczyk S., Parham C., Sleph P. The protective effects of cromakalim and pinacidil on reperfusion function and infarct size in isolated perfused rat hearts and anesthetized dogs. Cardiovasc. Drugs Ther. 4:1990;465-474.
23. + loss in a model of ischaemia in perfused guinea pig hearts in vitro. Eur. J. Pharmacol. 220:1992;231-236.
24. Hearse D.J., Tosaki A. Free radicals and calcium: simultaneous interacting triggers as determinants of vulnerability to reperfusion-induced arrhythmias in the rat heart. J. Mol. Cell. Cardiol. 20:1988;213-223.
25. Ino T., Karaguenzian H.S., Hong K., Meesmann M., Mandel W.J., Peter T. Relation of monophasic action potential recorded with contact electrode to underlying transmembrane action potential properties in isolated cardiac tissues: a systematic microelectrode validation study. Cardiovasc. Res. 22:1988;255-264.
26. + channel in the mitochondrial inner membrane. Nature. 352:1991;244-247.
27. Jiang C., Mochizuki S., Poole-Wilson P.A., Harding S.E., MacLeod K.T. Effect of lemakalim on action potentials, intracellular calcium, and contraction in guinea pig and human cardiac myocytes. Cardiovasc. Res. 28:1994;851-857.
28. + loss and arrhythmias in rat hearts: effect of glibenclamide, a sulphonylurea. Circ. Res. 66:1990;478-485.
29. Kaplinsky E., Ogawa S., Michelson E.L., Dreifus L.S. Instantaneous and delayed ventricular arrhythmias after reperfusion of acutely ischemic myocardium: evidence for multiple mechanisms. Circulation. 63:1981;333-340.
30. Kempsford R.D., Hawgood B.J. Assessment of the antiarrhythmic activity of nicorandil during myocardial ischemia and reperfusion. Eur. J. Pharmacol. 163:1989;61-68.
31. Montrucchio G., Alloati G., Tetta C., De Luca R., Saunders R.N., Emanuelli G., Camussi G. Release of platelet-activating factor from ischemic-reperfused rabbit heart. Am. J. Physiol. 256:1989;H1236-H1246.
32. Naimi S., Avitall B., Mieszala J., Levine H.J. Dispersion of effective refractory period during abrupt reperfusion of ischemic myocardium in dogs. Am. J. Cardiol. 39:1977;407-412.
33. + channel in cardiac muscle. Nature. 305:1983;147-148.
34. Paciorek P.M., Burden D.T., Burke Y.M., Cowlrick I.S., Perkins R.S., Taylor J.C., Waterfall J.F. Preclinical pharmacology of Ro 31-6930, a new potassium channel opener. J. Cardiovasc. Pharmacol. 15:1990;188-197.
35. Penny W.J., Sheridan D.J. Arrhythmias and cellular electrophysiological changes during myocardial "ischaemia" and reperfusion. Cardiovasc. Res. 17:1983;363-372.
36. Perchenet L., Kreher P. Mechanical and electrophysiological effects of preconditioning in isolated ischemic/reperfused rat hearts. J. Cardiovasc. Pharmacol. 26:1995;831-840.
37. Pogwizd S.M., Corr P.B. Electrophysiologic mechanisms underlying arrhythmias due to reperfusion of ischemic myocardium. Circulation. 76:1987;404-426.
38. 2+ concentration. Mol. Cell. Biochem. 186:1998;79-86.
39. 1 blocker, RP58866, assessed using the rat dual coronary perfusion model. J. Mol. Cell. Cardiol. 27:1995;2595-2606.
40. Rees S.A., Curtis M.J. Pharmacological analysis in rat of the role of the ATP-sensitive potassium channel as a potential target for antifibrillatory intervention in acute myocardial ischaemia. J. Cardiovasc. Pharmacol. 26:1995;280-288.
41. Rubin D.A., Nieminski K.E., Monteferrante J.C., Magee T., Reed G.E., Herman M.V. Ventricular arrhythmias after coronary artery bypass graft surgery: incidence, risk factors and long-term prognosis. J. Am. Coll. Cardiol. 6:1985;307-310.
42. ATP channels in cardioprotection. Basic Res. Cardiol. 95:2000;285-289.
43. Tanaka H., Okazaki K., Shigenobu K. Cardioprotective effects of NIP-121, a novel ATP-sensitive potassium channel opener, during ischemia and reperfusion in coronary perfused guinea pig myocardium. J. Cardiovasc. Pharmacol. 27:1996;695-701.
44. 2+ imbalance. Basic Res. Cardiol. 86:1991;340-354.
45. Tanonaka K., Taguchi T., Koshimizu M., Ando T., Morinaka T., Yogo T., Konishi F., Takeo S. Role of an ATP-sensitive potassium channel opener, YM934, in mitochondrial energy production in ischemic/reperfused heart. J. Pharmacol. Exp. Ther. 291:1999;710-716.
46. Tominaga M., Horie M., Matsumori A. Glibenclamide, an ATP-sensitive K channel blocker, inhibits cardiac A-kinase-dependent Cl conductance. Circulation. 86(Suppl. I):1992;I-695.
47. Tosaki A., Szerdahelyi P., Engelman R.M., Das D.K. Potassium channel openers and blockers: do they possess proarrhythmic or antiarrhythmic activity in ischemic and reperfused rat hearts? J. Pharmacol. Exp. Ther. 267:1993;1355-1362.
48. Tzivoni D., Keren A., Granot H., Gottleib S., Benhorin J., Stern S. Ventricular fibrillation caused by myocardial reperfusion in Prinzmetal's angina. Am. Heart J. 105:1983;323-325.
49. Vera Z., Pride H.P., Zipes D.P. Reperfusion arrhythmias: role of early afterdepolarizations studied by monophasic action potential recordings in the intact canine heart during autonomically denervated and stimulated states. J. Cardiovasc. Electrophysiol. 6:1995;532-543.
50. Walker M.J.A., Curtis M.J., Hearse D.J., Campbell R.W.F., Janse M.J., Yellon D.M., Cobbe S.M., Coker S.J., Harness J.B., Harron D.W.G., Higgins A.J., Julian D.G., Lab M.J., Manning A.S., Northover B.J., Parratt J.R., Riemersma R.A., Riva E., Russel D.C., Sheridan D.J., Winslow E., Woodward B. The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia, infarction, and reperfusion. Cardiovasc. Res. 22:1988;447-455.
51. K.ATP during acute myocardial ischemia: controversies revive. Cardiovasc. Res. 35:1997;181-183.
52. Wilde A.A.M., Janse M.J. Electrophysiological effects of ATP-sensitive potassium channel modulation: implications for arrhythmogenesis. Cardiovasc. Res. 28:1994;16-24.
53. Wilde A.A.M., Escande D., Schumacher C.A., Thuringer D., Mestre M., Fiolet J.W.T., Janse M.J. Potassium accumulation in the globally ischemic mammalian heart: a role for the ATP-sensitive potassium channel. Circ. Res. 67:1990;835-843.
54. Wolleben C.D., Sanguinetti M.C., Siegl P.K.S. Influence of ATP-sensitive potassium channel modulators on ischaemia-induced fibrillation in isolated rat hearts. J. Mol. Cell. Cardiol. 21:1989;783-788.
55. ATP) channels in cardiac arrhythmias in rat isolated hearts. Br. J. Pharmacol. 112:1994;. 386 pp. (Abstract).
56. ATP channels open as a prominent and early feature during ischaemia in the Langendorff-perfused rat heart? Basic Res. Cardiol. 95:2000;250-260.